Transaction · 0001395064-26-000347

Bitetti Teresa Marie

Bitetti Teresa Marie, PRES, OBU, reported an open-market or private sale at TAKEDA PHARMACEUTICAL CO LTD involving 46609.000000 shares. Reported holdings after the transaction were 214501.000000 shares. A 10b5-1 reference was not detected in the stored filing text.

Open-market sellSEC transaction code SPRES, OBU
TAKTAKEDA PHARMACEUTICAL CO LTD
Trade date
Nov 02, 2026
Filing date
Nov 04, 2026
View on SEC Insider profile
Disclosed valueUnknownShares × reported price
Shares traded46.6kPrice unknown
Holdings after214kDirect
% of reported position traded17.85%This security and ownership context
How reported position traded is calculated

Shares sold ÷ (holdings after + shares sold). Estimated position before: 261,110 shares.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Filing warnings

Notes recorded with this filing
1 warning
missing priceThe filing did not provide a usable price per share.

TAK price since this filing

Daily closing prices, with the filing date and available return windows
TAK · Daily closing priceLoading daily prices…
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago -8.2%1w ago +0.0%1d ago +0.0%
Returns since7d30d90d180d1y

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
Sell
Code S
Identifier
0001395064-26-000347
American Depositary Shares
Transaction date
Nov 02, 2026
Filed Nov 04, 2026, 10:35 PM · 2d delay
Shares
46,609 sh
Price unknown
Estimated value
—
Computed from shares × price
Holdings after
214,501 sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $100kLarge $1.00M
Direct Ownership
Filing-only score

+2 points

Compact filing score computed from stored Form 4 facts. Version v1.

Neutral filing signal

This filing is broadly neutral on the filing-only scale. The Form 4 facts do not strongly tilt positive or negative.

How this score is calculated
  • direct_ownership+6 points

    direct_or_indirect_ownership = D

    Direct ownership reports the insider's personal stake.
  • timely_filing+4 points

    reporting_delay_days = 2

    Filing reported within two business days of the transaction.
  • missing_price-8 points

    price_cents is null

    Missing price reduces confidence in value-based signals.
Missing facts
  • price_cents
Read the scoring methodology

Signed filing-only points, not a probability or expected return. Version v1.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

President, OBU

Officer YesDirector No10% NoOther No
Footnotes & amended
  1. F1

    Includes 9,100 ADS received upon the vesting of dividend equivalent units that were not included in the reporting person's previously filed Form 4.

Original filing · 0001395064-26-000347
Related transactions

0 other transactions

Same SEC filing
Recent company activity

0 recent txs

TAK